CommunityPharmacy UK

Community pharmacy news in the UK for pharmacists, independent prescribers, pre-regs, dispensers, technicians, ACTs & pharmacy students

[CommunityPharmacy UK @cpharmUK]

Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme: Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless the conditions of a Pregnancy Prevention Programme are… https://t.co/T6Y9GsxXBB

[CommunityPharmacy UK @cpharmUK]

Warfarin: be alert to the risk of drug interactions with tramadol: Taking warfarin and tramadol together can cause harmful drug interactions, which can raise the International Normalised Ratio (INR), and result in severe bruising and bleeding, which in… https://t.co/BZ7l2CUPnW

[CommunityPharmacy UK @cpharmUK]

Letters and medicine recalls sent to healthcare professionals in May 2024: A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. https://t.co/R8uWLepM3G

[CommunityPharmacy UK @cpharmUK]

Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions: Topical steroid products are safe and highly effective treatments for the management of a wide range… https://t.co/Xo0N5XdMkw

[CommunityPharmacy UK @cpharmUK]

Letters and medicine recalls sent to healthcare professionals in April 2024: A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device… https://t.co/rp4JOSnxR8

[CommunityPharmacy UK @cpharmUK]

Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment): A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of… https://t.co/rBbWfXzfjU

[CommunityPharmacy UK @cpharmUK]

Montelukast: reminder of the risk of neuropsychiatric reactions: Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric… https://t.co/XTXZw67noT

[CommunityPharmacy UK @cpharmUK]

Letters and medicine recalls sent to healthcare professionals in March 2024: A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. https://t.co/PLbR87S06V

[CommunityPharmacy UK @cpharmUK]

Transition to new GPhC website: Tuesday 23 April: We are planning to launch our new corporate website on Tuesday 23 April.

We are expecting the website to be unavailable for at least two hours from 9am on Tuesday, while we switch from our current… https://t.co/LcYTj4lQta

[CommunityPharmacy UK @cpharmUK]

GPhC Council meeting on 18 April 2024: The Council of the GPhC will be meeting on Thursday 18 April.

Please contact our Council secretary by 4pm on Wednesday 17 April 2024, if you would like to attend the meeting.  https://t.co/cte90VSopW

[CommunityPharmacy UK @cpharmUK]

Contact centre closure - Thursday 11 April 2024: The contact centre will be closed on Thursday 11 April between 10.00am – 12.00pm due to training purposes.  https://t.co/Wuvxjq2yz9

[CommunityPharmacy UK @cpharmUK]

GPhC launches consultation on the quality assurance of pharmacy education and training​: The General Pharmaceutical Council is seeking views on changing its approach to the quality assurance of pharmacy education and training. https://t.co/Wi8Azrr2nu

[CommunityPharmacy UK @cpharmUK]

Letters and medicine recalls sent to healthcare professionals in February 2024: A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. https://t.co/AULQrjdHtM

[CommunityPharmacy UK @cpharmUK]

NHS England clinical policy on puberty suppressing hormones: NHS England has recently published its clinical policy on puberty suppressing hormones. This sets out that puberty suppressing hormones are not available as a routine commissioning treatment… https://t.co/Vj3xbENfQc

[CommunityPharmacy UK @cpharmUK]

Our Contact Centre on Thursday 21 March: The contact centre will be closed today between 12.30-1.30pm for training, but will re-open again from 1.30pm.

During this time please email any enquiries to [email protected]. https://t.co/mU7PVlMoJW

[CommunityPharmacy UK @cpharmUK]

Tackling discrimination and bias: our hearings and outcomes guidance: The GPhC has published updated hearings and outcomes guidance for decision-makers in fitness to practise cases.

We consulted on changes to our hearings and outcomes guidance for… https://t.co/abxLqXrU6m

[CommunityPharmacy UK @cpharmUK]

The majority of pharmacy technicians feel well prepared for practice after training according to new research: Research commissioned by the GPhC examined how the 2017 standards for the initial education and training of pharmacy technicians (IETPT) have… https://t.co/AW75U4N2bh

[CommunityPharmacy UK @cpharmUK]

Contact centre on 7 March 2024: The contact centre will be closed on the morning of Thursday 7 March for training purposes and will reopen again at 1pm on the same day.

During this time please email any enquiries to [email protected]. https://t.co/iU9TWjkBRU

[CommunityPharmacy UK @cpharmUK]

Racism and language barriers in pharmacy – insights and actions following our roundtable events: The General Pharmaceutical Council has published new reports on racism and other inequalities in pharmacy following our roundtable event. https://t.co/GTpLth2ztg

[CommunityPharmacy UK @cpharmUK]

GPhC appoints new Chair of the Board of Assessors: The General Pharmaceutical Council has appointed Dr Mat Smith as the new Chair of the Board of Assessors.

The role of the Board of Assessors is to assure the registration assessment, through setting… https://t.co/kXmudQGmSl